Il-15 Superagonist and Dinutuximab significantly Enhance Expanded Natural Killer Cell Activity Against Gd2(+) Pediatric Solid Tumors (ST)

Author Type(s)

Faculty, Student

Document Type

Abstract

Publication Date

6-2019

Journal Title

Pediatric Blood & Cancer

Department

Pediatrics

Second Department

Pharmacology

This document is currently not available here.

Share

COinS